Quad member countries condemn 'reprehensible' Delhi Red Fort blast, call for justice
IndiGo mass flight cancellations to continue on Sunday? Here's what the airline said
KL Rahul admits ignoring Virat Kohli's advice, reveals brain behind India's left-hand toss move
Viral video shows German woman’s shock at Delhi’s chaotic traffic, calls experience ‘roller coaster’
What is Right to Disconnect Bill 2025, introduced in Lok Sabha? Can it be passed?
INDIA
The Drug Controller General of India has allowed Bharat Biotech India (BBIL) to conduct human clinical trials for ‘COVAXIN’, a potential COVID-19 vaccine. The human clinical trials will start across India in July 2020. If it emerges successful, COVAXIN will be available by year’s end.
The Drug Controller General of India has allowed Bharat Biotech India (BBIL) to conduct human clinical trials for ‘COVAXIN’, a potential COVID-19 vaccine. The human clinical trials will start across India in July 2020. If it emerges successful, COVAXIN will be available by year’s end.